Angiotensin-converting enzyme inhibitors can be a risk factor for lung cancer!!

dc.contributor.author	Altalhe, Heba Abdalnasser Azouz
dc.date.accessioned	2019-06-25T09:09:41Z
dc.date.available	2019-06-25T09:09:41Z
dc.date.issued	2019-04-09
dc.identifier.uri	http://repository.limu.edu.ly/handle/123456789/991
dc.description	Angiotensin converting enzyme inhibitors (ACE inhibitors) are medications that inhibit the activity of the enzyme ACE, which decreases the production of angiotensin II. As a result, blood vessels dilate, and blood pressure is reduced ,the are effective drugs used in the treatment of hypertension[1]. Although these drugs have been shown to be relatively safe in the short term, concerns have been raised that their long term use may be associated with an increased risk of cancer. [2],The Some biological evidence exists for a possible association between ACEIs and risk of lung cancer.	en_US
dc.language.iso	en	en_US
dc.publisher	faculty of Basic Medical Science - Libyan International Medical University	en_US
dc.rights	Attribution 3.0 United States	*
dc.rights.uri	http://creativecommons.org/licenses/by/3.0/us/	*
dc.title	Angiotensin-converting enzyme inhibitors can be a risk factor for lung cancer!!	en_US
dc.type	Other	en_US

Except where otherwise noted, this item's license is described as Attribution 3.0 United States